Gevo downgraded to Sell from Buy at UBS UBS downgraded Gevo due to the Isobutanol production halt and lack of visibility. Price target lowered to $1 from $9.
News For GEVO From The Last 14 Days
Check below for free stories on GEVO the last two weeks.